Primary cutaneous T-cell lymphoma

This early-stage trial is testing a new form of fenretinide (a vitamin A-like drug) given by IV for people with T-cell non-Hodgkin lymphoma that has come back or stopped responding to treatment. The study has two parts: first, finding the safest dose in small groups of patients, …

This study is creating a large database of information and tissue samples from 1,000 people with T-cell lymphoma. Researchers will use this data to learn more about the disease and how to improve patient outcomes. Participants provide medical information and optional blood and na…

This study is a registry that will collect information from about 600 people with primary cutaneous T-cell lymphoma, a rare type of skin cancer. Researchers will look back at past cases and follow new ones to understand how common different forms of the disease are and how long p…